Atlas Trials

Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis

Clinical trial NCT05610956 · RECRUITING

Trial details

NCT number
NCT05610956
Sponsor
Tanta University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2023-01-01
Primary completion
2025-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.